Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Review of Marathon

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jul 31, 2023 10:53am

97 Views

Post# 35564685

RE:RE:RE:RE:RE:RE:RE:Review of Marathon

It's one thing to be upset about this dumpster fire of a stock, it's completely stupid to blame spceo for your investments not working out like you had hoped, literally the dumbest most pathetic thing I have seen from grown adults. Trying to pin there failure on someone else..... I lost on this, but its my fault not his or anyone else's outside of the idiots at thera.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?